The global chemiluminescence immunoassay market is projected to reach USD 19.34 Billion by 2030, growing at a CAGR of 7.8% during the forecast period. The market is driven by the widespread application of CLIA in detecting chronic diseases and its use in therapeutic drug monitoring by pharmaceutical companies and research institutes.
Previous ArticleRobots To Make Banana Processing More A-peeling
Next Article Aiming Ai At Cancer-related Biomarkers